4527 — Rohto Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥666bn
- ¥658bn
- ¥344bn
Board Opposes Shareholder Proposal By Avi Japan Opportunity Trust Regarding Dismissal Of One Director
Table: Rohto -2025/26 group results
Table: Rohto -2025/26 parent results
Notice Of Receipt Of Shareholder Proposals
L'Oreal 'returns to form' in Q1, shares rise
To Buy Back Up To 0.66% Of Own Shares Worth 3 Billion Yen
Table: Rohto - 9-MTH group results
Acquisition Of Shares Of Thailand-Based Wellness-Related Company, Thann Oryza
Table: Rohto - 6-MTH group results
Table: Rohto -Q1 group results
Table: Rohto -2024/25 parent results
Table: Rohto -2024/25 group results
Managing Director Hidetoshi Segi To Become President And COO Pending Approval At Shareholders Meeting In June
UK fund Asset Value Investors launches campaign against Japan's Wacom (updated)
UK fund Asset Value Investors launches campaign against Japan's Wacom
Brief: Asset Value Investors Urges Rohto Pharmaceutical To Focus On Core Businesses
Brief: Asset Value Investors - Calling Rohto Pharmaceutical To Focus On Its Core Businesses Rather Than Allocating Resources To Regenerative Medicine Business
Company Resolves To Acquire Own Shares
Table: Rohto - 9-MTH group results